Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (S,R) 8 benzyl 7,9 dioxo 2,8 diazabicyclo[4.3.0]nonane. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112724129A details a novel chiral purification method for moxifloxacin intermediates, offering superior ee values and scalable industrial production for reliable supply chains.
Patent CN112707901A reveals a cost-effective resolution method for moxifloxacin side chains using gulonic acid, offering >98% ee and simplified manufacturing for reliable API intermediate supply.